Wei‐Jan Wang

2.3k total citations
42 papers, 842 citations indexed

About

Wei‐Jan Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Wei‐Jan Wang has authored 42 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Infectious Diseases. Recurrent topics in Wei‐Jan Wang's work include SARS-CoV-2 and COVID-19 Research (8 papers), MicroRNA in disease regulation (5 papers) and Ferroptosis and cancer prognosis (5 papers). Wei‐Jan Wang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), MicroRNA in disease regulation (5 papers) and Ferroptosis and cancer prognosis (5 papers). Wei‐Jan Wang collaborates with scholars based in Taiwan, United States and China. Wei‐Jan Wang's co-authors include Wei‐Wen Kuo, Mien‐Chie Hung, Chien‐Feng Li, Hsi‐Hsien Hsu, Gangga Anuraga, Hoang Dang Khoa Ta, Cheng‐Wen Lin, Chih‐Yang Wang, Tung‐Yuan Lai and Pei‐Ying Pai and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Wei‐Jan Wang

38 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Jan Wang Taiwan 16 419 151 108 104 98 42 842
Jiahui Li China 20 363 0.9× 179 1.2× 72 0.7× 102 1.0× 133 1.4× 55 976
Yingchun Zhou China 23 619 1.5× 155 1.0× 120 1.1× 136 1.3× 130 1.3× 67 1.2k
Yongliang Yuan China 17 475 1.1× 222 1.5× 98 0.9× 82 0.8× 66 0.7× 31 832
Zihui Zhang China 19 497 1.2× 151 1.0× 97 0.9× 78 0.8× 145 1.5× 64 989
Jian Lv China 17 598 1.4× 174 1.2× 81 0.8× 253 2.4× 101 1.0× 38 950
Shenglan Yang China 9 412 1.0× 172 1.1× 102 0.9× 93 0.9× 70 0.7× 14 702
Dan Huang China 18 753 1.8× 228 1.5× 108 1.0× 223 2.1× 118 1.2× 56 1.3k
Zhiqiang Zheng China 18 569 1.4× 111 0.7× 45 0.4× 115 1.1× 89 0.9× 49 1.0k
Lei Zhu China 18 609 1.5× 149 1.0× 62 0.6× 117 1.1× 135 1.4× 58 1.0k

Countries citing papers authored by Wei‐Jan Wang

Since Specialization
Citations

This map shows the geographic impact of Wei‐Jan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Jan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Jan Wang more than expected).

Fields of papers citing papers by Wei‐Jan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Jan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Jan Wang. The network helps show where Wei‐Jan Wang may publish in the future.

Co-authorship network of co-authors of Wei‐Jan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Jan Wang. A scholar is included among the top collaborators of Wei‐Jan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Jan Wang. Wei‐Jan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Wei‐Jan, Wan‐Jou Shen, Chih‐Jung Chen, et al.. (2025). miR-6126 modulates GRP78 to suppress the Warburg effect and mitochondrial dynamics in triple-negative breast cancer. International Journal of Medical Sciences. 22(14). 3598–3616. 1 indexed citations
3.
Wang, Chi‐Yun, et al.. (2025). Tumor-derived lactate fuels the STAT3-LCN2 pathway to promote bladder cancer malignancy and chemoresistance. Scientific Reports. 15(1). 41610–41610.
4.
Wang, Wei‐Jan, Wan‐Jou Shen, Chung‐Yu Chen, et al.. (2024). Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula. Cancer Letters. 604. 217198–217198.
5.
Shen, Wan‐Jou, Chih‐Yang Wang, Ching‐Chung Ko, et al.. (2024). Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer. International Journal of Medical Sciences. 21(11). 2158–2169. 2 indexed citations
6.
Sun, Xian Wen, Wei‐Jan Wang, Ri‐Yao Yang, et al.. (2023). Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity. International Journal of Biological Sciences. 19(14). 4644–4656. 8 indexed citations
7.
Su, Wen‐Chi, King-Song Jeng, Yu‐Chi Chou, et al.. (2023). Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization. Antiviral Research. 220. 105744–105744. 4 indexed citations
8.
Wang, Chin‐Chou, Wan‐Jou Shen, Gangga Anuraga, et al.. (2022). Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer. Journal of Personalized Medicine. 12(12). 1947–1947. 6 indexed citations
9.
Lee, Yu‐Cheng, Wei‐Lun Chang, Wei‐Jan Wang, et al.. (2022). Concurrent Chemoradiotherapy-Driven Cell Plasticity by miR-200 Family Implicates the Therapeutic Response of Esophageal Squamous Cell Carcinoma. International Journal of Molecular Sciences. 23(8). 4367–4367. 3 indexed citations
10.
Wang, Chin‐Chou, Wan‐Jou Shen, Gangga Anuraga, et al.. (2022). Penetrating Exploration of Prognostic Correlations of the FKBP Gene Family with Lung Adenocarcinoma. Journal of Personalized Medicine. 13(1). 49–49. 7 indexed citations
11.
Chiang, Hsiu‐Mei, Yeh Chen, Chung‐Yu Chen, et al.. (2022). Prospects of Coffee Leaf against SARS-CoV-2 Infection. International Journal of Biological Sciences. 18(12). 4677–4689. 13 indexed citations
12.
Chiang, En‐Pei Isabel, Raymond L. Rodriguez, Wei‐Jan Wang, et al.. (2022). N-3 polyunsaturated fatty acids block the trimethylamine-N-oxide- ACE2- TMPRSS2 cascade to inhibit the infection of human endothelial progenitor cells by SARS-CoV-2. The Journal of Nutritional Biochemistry. 109. 109102–109102. 9 indexed citations
13.
Anuraga, Gangga, Wei‐Jan Wang, Nam Nhut Phan, et al.. (2021). Potential Prognostic Biomarkers of NIMA (Never in Mitosis, Gene A)-Related Kinase (NEK) Family Members in Breast Cancer. Journal of Personalized Medicine. 11(11). 1089–1089. 58 indexed citations
14.
Shen, Wan‐Jou, Gangga Anuraga, Hoang Dang Khoa Ta, et al.. (2021). Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma. Biomedicines. 9(11). 1601–1601. 19 indexed citations
15.
Ta, Hoang Dang Khoa, Wei‐Jan Wang, Nam Nhut Phan, et al.. (2021). Potential Therapeutic and Prognostic Values of LSM Family Genes in Breast Cancer. Cancers. 13(19). 4902–4902. 31 indexed citations
16.
Huang, Sheng‐Teng, Yeh Chen, Wei‐Chao Chang, et al.. (2021). Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Viruses. 13(5). 826–826. 24 indexed citations
17.
Wang, Shao‐Chun, Yeh Chen, Yuchuan Wang, et al.. (2020). Tannic acid suppresses SARS-CoV-2 as a dual inhibitor of the viral main protease and the cellular TMPRSS2 protease. American Journal of Cancer Research. 10(12). 4538–4546. 66 indexed citations
18.
Wang, Wei‐Jan, Chien‐Feng Li, Yu‐Yi Chu, et al.. (2016). Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder. Clinical Cancer Research. 23(2). 503–513. 51 indexed citations
19.
Chu, Yu‐Yi, Chiung‐Yuan Ko, Wei‐Jan Wang, et al.. (2015). Astrocytic CCAAT/Enhancer Binding Protein δ Regulates Neuronal Viability and Spatial Learning Ability via miR-135a. Molecular Neurobiology. 53(6). 4173–4188. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiahui Li Breakdown of academic impact, for papers by Yingchun Zhou Breakdown of academic impact, for papers by Yongliang Yuan Breakdown of academic impact, for papers by Zihui Zhang Breakdown of academic impact, for papers by Jian Lv Breakdown of academic impact, for papers by Shenglan Yang Breakdown of academic impact, for papers by Dan Huang Breakdown of academic impact, for papers by Zhiqiang Zheng Breakdown of academic impact, for papers by Lei Zhu
Rankless by CCL
2026